227 related articles for article (PubMed ID: 31454671)
1. Targeting integrins for cancer management using nanotherapeutic approaches: Recent advances and challenges.
Ahmad K; Lee EJ; Shaikh S; Kumar A; Rao KM; Park SY; Jin JO; Han SS; Choi I
Semin Cancer Biol; 2021 Feb; 69():325-336. PubMed ID: 31454671
[TBL] [Abstract][Full Text] [Related]
2. Drug delivery approaches for breast cancer.
Singh SK; Singh S; Lillard JW; Singh R
Int J Nanomedicine; 2017; 12():6205-6218. PubMed ID: 28883730
[TBL] [Abstract][Full Text] [Related]
3. Integrin-Targeted Peptide- and Peptidomimetic-Drug Conjugates for the Treatment of Tumors.
Arosio D; Manzoni L; Corno C; Perego P
Recent Pat Anticancer Drug Discov; 2017; 12(2):148-168. PubMed ID: 28164756
[TBL] [Abstract][Full Text] [Related]
4. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
[TBL] [Abstract][Full Text] [Related]
5. Integrin targeted drug and gene delivery.
Wang Z; Chui WK; Ho PC
Expert Opin Drug Deliv; 2010 Feb; 7(2):159-71. PubMed ID: 20095940
[TBL] [Abstract][Full Text] [Related]
6. Bio-vehicles of cytotoxic drugs for delivery to tumor specific targets for cancer precision therapy.
Al-Mansoori L; Elsinga P; Goda SK
Biomed Pharmacother; 2021 Dec; 144():112260. PubMed ID: 34607105
[TBL] [Abstract][Full Text] [Related]
7. Strategies to inhibit tumor associated integrin receptors: rationale for dual and multi-antagonists.
Sheldrake HM; Patterson LH
J Med Chem; 2014 Aug; 57(15):6301-15. PubMed ID: 24568695
[TBL] [Abstract][Full Text] [Related]
8. Improved Targeting of Cancers with Nanotherapeutics.
Foster C; Watson A; Kaplinsky J; Kamaly N
Methods Mol Biol; 2017; 1530():13-37. PubMed ID: 28150194
[TBL] [Abstract][Full Text] [Related]
9. Molecular Targeting of Integrins and Integrin-Associated Signaling Networks in Radiation Oncology.
Vehlow A; Storch K; Matzke D; Cordes N
Recent Results Cancer Res; 2016; 198():89-106. PubMed ID: 27318682
[TBL] [Abstract][Full Text] [Related]
10. Implications of nanotechnology for the treatment of cancer: Recent advances.
Klochkov SG; Neganova ME; Nikolenko VN; Chen K; Somasundaram SG; Kirkland CE; Aliev G
Semin Cancer Biol; 2021 Feb; 69():190-199. PubMed ID: 31446004
[TBL] [Abstract][Full Text] [Related]
11. Nanotherapy Targeting the Tumor Microenvironment.
Gong BS; Wang R; Xu HX; Miao MY; Yao ZZ
Curr Cancer Drug Targets; 2019; 19(7):525-533. PubMed ID: 30569855
[TBL] [Abstract][Full Text] [Related]
12. Smart Drug-Delivery Systems for Cancer Nanotherapy.
Sanchez-Moreno P; Ortega-Vinuesa JL; Peula-Garcia JM; Marchal JA; Boulaiz H
Curr Drug Targets; 2018 Feb; 19(4):339-359. PubMed ID: 27231107
[TBL] [Abstract][Full Text] [Related]
13. Nanotherapeutic approaches for brain cancer management.
Saenz del Burgo L; Hernández RM; Orive G; Pedraz JL
Nanomedicine; 2014 Jul; 10(5):905-19. PubMed ID: 24135564
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions.
Anchordoquy TJ; Barenholz Y; Boraschi D; Chorny M; Decuzzi P; Dobrovolskaia MA; Farhangrazi ZS; Farrell D; Gabizon A; Ghandehari H; Godin B; La-Beck NM; Ljubimova J; Moghimi SM; Pagliaro L; Park JH; Peer D; Ruoslahti E; Serkova NJ; Simberg D
ACS Nano; 2017 Jan; 11(1):12-18. PubMed ID: 28068099
[TBL] [Abstract][Full Text] [Related]
15. Smart Nanotherapeutic Targeting of Tumor Vasculature.
Li Z; Di C; Li S; Yang X; Nie G
Acc Chem Res; 2019 Sep; 52(9):2703-2712. PubMed ID: 31433171
[TBL] [Abstract][Full Text] [Related]
16. CCR 20th Anniversary Commentary: Prospects and Challenges of Therapeutic Nanoparticles in Cancer.
Rahman MA; Shin DM
Clin Cancer Res; 2015 Oct; 21(20):4499-501. PubMed ID: 26473185
[TBL] [Abstract][Full Text] [Related]
17. Targeting integrins in hepatocellular carcinoma.
Wu Y; Qiao X; Qiao S; Yu L
Expert Opin Ther Targets; 2011 Apr; 15(4):421-37. PubMed ID: 21332366
[TBL] [Abstract][Full Text] [Related]
18. Integrins Within the Tumor Microenvironment: Biological Functions, Importance for Molecular Targeting, and Cancer Therapeutics Innovation.
Dzobo K
OMICS; 2021 Jul; 25(7):417-430. PubMed ID: 34191612
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Associated Fibroblast-Targeting Nanoparticles for Enhancing Solid Tumor Therapy: Progress and Challenges.
Li W; Little N; Park J; Foster CA; Chen J; Lu J
Mol Pharm; 2021 Aug; 18(8):2889-2905. PubMed ID: 34260250
[TBL] [Abstract][Full Text] [Related]
20. The complexity of integrins in cancer and new scopes for therapeutic targeting.
Hamidi H; Pietilä M; Ivaska J
Br J Cancer; 2016 Oct; 115(9):1017-1023. PubMed ID: 27685444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
